The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations.

doi:10.1046/j.1365-2796.1998.00338.x

Back to search

Article

The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations.

Journal of internal medicine - 1 Jun 1998

Wittebol-Post D, Hes F J, Lips C J

Abstract excerpt

Von Hippel-Lindau disease (VHL) is an autosomal dominant tumour syndrome caused by germline mutations of the VHL tumour suppressor gene located on chromosome 3p25-26. In VHL tumours may occur in 14 different target organs, including the eye. Retinal angiomas are considered the first manifestation...

Topics

Adult
Female
Follow-Up Studies
Genetic Testing
Genotype
Hemangioma
Humans
Male
Pedigree
Phenotype
Retinal Neoplasms
Vision Screening
von Hippel-Lindau Disease

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.